SEC Form 4 · accession 0001144204-15-059997
IMMUNE PHARMACEUTICALS INC · IMNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Gedeon Teper
Officer — CEO · Director
Period of report
Oct 19, 2015
Accepted (ET)
Oct 19, 2015 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001208261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 19, 2015 | P | 18,600 | $1.344 | A | 4,539,505 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported in this line item was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2015.